Task force issues guidance for in vitro diagnostic device classification

09/19/2008 | FDAnews

The Global Harmonization Task Force's Study Group 1 has published its final guidance for classifying in vitro diagnostic medical devices. A four-tiered, risk-based system should be specifically designed for categorizing such products, according to the guidance.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX